Biobliss Information

BIOBLISS is designed, developed and manufactured in the USA by Iontera, Inc. Iontera is pioneering the development of intelligent transdermal patches based on the IonIQ™ platform. The Company is applying advancements in miniaturization and electronics packaging to provide active transdermal infusion technology for the next generation of drug delivery. Active transdermal infusion is a method whereby electro-stimulation is used to drive molecules of interest across the skin non-invasively in a controlled and repeatable manner. Unlike passive transdermal technologies, which rely on nature to produce results (e.g. osmosis), and which are slow and only allow small amounts of drugs to cross the skin, or dual-electrode iontophoresis technologies, which form a circuit to force the molecules into the skin, often resulting in irritation and burning, the Iontera patented single electrode technology pushes molecules into the skin painlessly in high enough quantities to open up new avenues in transdermal applications. The IonIQ patch's design and novelty are protected by Iontera's intellectual property rights, including one approved and issued patent and seven pending patent applications. Iontera was founded in 2007 and is led by a veteran team with deep expertise in consumer products, medical devices, materials and systems design. Iontera is located in Providence, Rhode Island." For more details, please visit the Iontera web site.